Methylin is a central nervous system stimulant that’s used for the treatment of attention-deficit disorder (ADD), attention-deficit/hyperactive disorder (ADHD) and narcolepsy. ADHD and ADD are thought to be linked to an underactivity of the neurotransmitters dopamine and norepinephrine. These neurotransmitters contribute to hyperactivity and impulse control. Methylin treats ADHD and narcolepsy by increasing activity of dopamine and norepinephrine in the brain.
Methylin can be addictive and should only be taken as prescribed by a doctor. Individuals who become addicted to Methylin have several options for drug treatment and rehab, including various types of inpatient and outpatient rehab.
Common side effects of prescribed Methylin use should not be confused with signs of addiction. Side effects of standard Methylin use can include trouble sleeping, weight loss, nausea, vomiting, nervousness and loss of appetite. A doctor should be notified immediately if more serious side effects occur. These can include restricted blood flow to the extremities (cold/pale fingers, toes, hands and feet), rapid or pounding heartbeat, mood swings or thoughts of suicides.
A medical history of uncontrolled muscle movements (Tourette’s syndrome), blood circulation problems, high blood pressure, heart failure, irregular heartbeat, heart attack, congenital heart abnormalities or a family history of heart problems should be shared with the prescribing doctor. A history of depression, anxiety, psychosis, bipolar disorder and other mental health disorders should also be disclosed.
The general phases of treatment for severely addicted patients may involve intervention with family and friends, medical detox, inpatient therapy, outpatient therapy and attendance of Alcohol Anonymous or Narcotics Anonymous meetings. Not everyone seeking treatment for Methylin addiction will need all levels of treatment.
Methylin addiction can present similarly to addiction to recreational methamphetamine usage. Individuals who regularly use Methylin at doses higher than are prescribed may experience feelings of paranoia, agitation, uncontrolled movements, verbal ticks, difficulty urinating, dangerously high body temperatures and feelings of hostility.
Medical detox is often necessary to monitor the patient’s post-acute withdrawal symptoms from chronic Methylin use. Withdrawal symptoms from Methylin use can include vivid nightmares, depression, fluctuations in heart rhythm, increased appetite, insomnia, dizziness, headache, constipation, dry mouth and poor motor control.
Many inpatient and outpatient rehab centers require medical detox before allowing admittance into their programs. Length of medical detox varies per the severity of addiction. Once the patient is declared medically stable and has made it through the rough part of withdrawals, they may be admitted to an inpatient or outpatient rehab facility.
For many cases of chronic stimulant misuse, inpatient treatment will be necessary. Inpatient treatment helps educate patients about the factors that drive their addictive behaviors. Being surrounded by people who are going through a similar experience can be beneficial to this process. In mild cases of Methylin misuse, inpatient treatment may not be necessary. For these individuals, outpatient programs are available. With outpatient treatment, individuals can continue to attend work and engage in family life without interruption.
Inpatient programs vary in length depending on the needs of the patient. Inpatient programs are typically four weeks long. During this time, individuals engage in both group counseling and one-on-one therapy sessions. Patients begin to gain an understanding of the science behind addiction. They also explore the various triggers and life events that pushed them to misuse Methylin. Methylin misuse can often be a coping mechanism for deeper underlying problems. Inpatient treatment can allow individuals to learn about addiction in a safe environment without the temptation of access the drug.
Outpatient rehab for Methylin misuse is an option for patients whose addiction is less severe. Outpatient programs are typically several months long. Individuals attend an average of three group therapy sessions a week, each roughly two hours in length. During this time, patients engage in group discussions and cover standard educational material on substance misuse. Attendance at Alcoholics Anonymous meetings and Narcotics Anonymous meetings may also be mandatory.
Deciding which type of rehabilitation is the right match for a given patient depends on their age and severity of the addiction. Inpatient and outpatient programs exist that cater exclusively to children. Adult-only rehab centers for Methylin and other substance misuse disorders also exist. Some inpatient treatment centers are gender specific, although these are less common.
Wilderness-based recovery programs are increasingly popular for adolescents. In these programs, individuals are sent into the wilderness with a small group of fellow recovering patients. Patients are accompanied by trained drug counselors and survival guides. This type of recovery program is a combination of substance misuse rehabilitation and character building.
The Recovery Village aims to improve the quality of life for people struggling with substance use or mental health disorder with fact-based content about the nature of behavioral health conditions, treatment options and their related outcomes. We publish material that is researched, cited, edited and reviewed by licensed medical professionals. The information we provide is not intended to be a substitute for professional medical advice, diagnosis or treatment. It should not be used in place of the advice of your physician or other qualified healthcare providers.